The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors
Abstract
Nanotechnology applied to biological problems represents an emerging field with the potential to offer extremely sensitive diagnostics and targeted cancer therapies. However, to achieve these goals, nanoparticle delivery systems must outwit the many barriers that are intrinsic to the body's defenses, as well as those that develop during the growth and progression of tumors. The science is advancing and, for example, true nanoscale tumor‐targeted drug delivery vectors are now able to reduce the likelihood of opsonization in the bloodstream and uptake by the reticuloendothelial system. Other advances hold promise for delivering multiple therapeutic agents to non‐homogeneous populations of cancer cells in solid tumors. We briefly summarize herein our attempts to build such multifunctional nanotherapeutics using colloidal gold nanoparticles. Specifically we discuss the development of colloidal gold‐based drugs that are designed to target the delivery of TNF and paclitaxel to solid tumors. Drug Dev. Res. 67:47–54, 2006. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A DNA-based method for rationally assembling nanoparticles into macroscopic materials
Mirkin, C. A., Letsinger, R. L., Mucic, R. C., & Storhoff, J. J. (1996) · Nature · doi:10.1038/382607a0 · Cited by 6,683
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
X. The Bakerian Lecture. —Experimental relations of gold (and other metals) to light
Faraday, M. (1857) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1857.0011 · Cited by 2,123
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Self-citationPluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Heterogeneity of tumor cells from a single mouse mammary tumor.
Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., & Heppner, G. H. (1978) · PubMed · Cited by 579
Nagayasu, A., Uchiyama, K., & Kiwada, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00041-1 · Cited by 437
Redhead, H. M., Davis, S. S., & Illum, L. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00367-9 · Cited by 419
Brett, J., Gerlach, H., Nawroth, P., Steinberg, S., Godman, G., & Stern, D. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.1977 · Cited by 409
Moghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91869-e · Cited by 282
The Role of the Sinus Wall in the Passage of Erythrocytes Through the Spleen
Chen, L.-T., & Weiss, L. (1973) · Blood · doi:10.1182/blood.v41.4.529.529 · Cited by 269
Controlling liposome blood clearance by surface-grafted polymers
Woodle, M. C. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00136-1 · Cited by 242
Moghimi, S. M., & Patel, H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00131-2 · Cited by 240
Effect of tumour necrosis factor on cultured human melanoma cells
HELSON, L., GREEN, S., CARSWELL, E., & OLD, L. J. (1975) · Nature · doi:10.1038/258731a0 · Cited by 238
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15223 · Cited by 238
Control of tumour vascular permeability
Baban, D. F., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00003-9 · Cited by 237
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
Curnis, F., Sacchi, A., & Corti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215223 · Cited by 228
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Transferrin As A Targeting Ligand for Liposomes and Anticancer Drugs
Singh, M. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280506230110111312 · Cited by 181
Koehne, J. E., Chen, H., Cassell, A. M., Ye, Q., Han, J., Meyyappan, M., & Li, J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.036285 · Cited by 166
Principles and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 147
Gottschalk, S. M., Cristiano, R. J., Smith, L. C., & Woo, S. L. C. (1994) · PubMed · Cited by 133
Líénard, D., Lejeune, F. J., & Ewalenko, P. (1992) · World Journal of Surgery · doi:10.1007/bf02071526 · Cited by 122
Kristensen, C. A., Nozue, M., Boucher, Y., & Jain, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.397 · Cited by 113
Rj, C., & Roth, J. A. (1996) · PubMed · Cited by 92
Papisov, M. I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00135-x · Cited by 90
Pharmacological treatment of nephropathic cystinosis with cysteamine
Kleta, R., & Gahl, W. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.11.2255 · Cited by 87
Immunoliposome Targeting to Mesangial Cells
Tuffin, G., Waelti, E. R., Huwyler, J., Hammer, C., & Marti, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050485 · Cited by 86
Lejeune, F. J. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00512-5 · Cited by 76
The distribution and radiation effects of intravenously administered colloidal Au198 in man
Root, S. W., Andrews, G. A., Kniseley, R. M., & Tyor, M. P. (1954) · Cancer · doi:10.1002/1097-0142(195409)7:5<856::aid-cncr2820070506>3.0.co;2-a · Cited by 73
Drug targeting systems for cancer chemotherapy
Sachdeva, M. S. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.11.1849 · Cited by 46
Effect of tumor necrosis factor-α, IL-1β, and IL-6 on interstitial fluid pressure in rat skin
Nedrebø, T., Berg, A., & Reed, R. K. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.5.h1857 · Cited by 33
Rubin, P., & Levitt, S. H. (1964) · PubMed · Cited by 19
Cited by
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Applications of Nanoparticles in Biology
De, M., Ghosh, P. S., & Rotello, V. M. (2008) · Advanced Materials · doi:10.1002/adma.200703183 · Cited by 1,547
Metadata
- Authors
- Paciotti, G. F., Kingston, D. G. I., & Tamarkin, L.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 67
- Issue
- 1
- Pages
- 47-54
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2122124176
- Cited by
- 484
- References
- 37
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.